Cargando…
New therapeutic applications of ozenoxacin in superficial skin infections
In recent years, the incidence of community- acquired methicillin-resistant S. aureus skin infections (CA-MARSA) has increased in pediatric population without associated risk factors. Ozenoxacin 10mg/g is a topical quinolone that has shown high activity on strains of S. aureus, S. pyogenes and other...
Autores principales: | García Ron, Gema, Villa Arranz, María |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9251530/ https://www.ncbi.nlm.nih.gov/pubmed/35795839 http://dx.doi.org/10.4081/dr.2021.9289 |
Ejemplares similares
-
Green Nail Syndrome Treated with Ozenoxacin: Two Case Reports
por: Cosio, Terenzio, et al.
Publicado: (2023) -
Uptake of Ozenoxacin and Other Quinolones in Gram-Positive Bacteria
por: López, Yuly, et al.
Publicado: (2021) -
The Use of Ozenoxacin in Pediatric Patients: Clinical Evidence, Efficacy and Safety
por: Davino, Giusy, et al.
Publicado: (2020) -
Safety and efficacy profile of ozenoxacin 1% cream in pediatric patients with impetigo()
por: Hebert, Adelaide A., et al.
Publicado: (2019) -
Anti-inflammatory effects of ozenoxacin, a topical quinolone antimicrobial agent
por: Tabara, Keisuke, et al.
Publicado: (2020)